Trials / Withdrawn
WithdrawnNCT05708989
Caudal vs. Pudendal Block in Peds GU
Caudal vs. Pudendal Block for Early Postoperative Pain Control in a Pediatric Population Undergoing Lower Genitourinary Surgery
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University Hospitals Cleveland Medical Center · Academic / Other
- Sex
- Male
- Age
- 6 Months – 3 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare two techniques to minimize pain during and after penile surgery in children undergoing certain urologic surgeries. These two approaches include the caudal nerve block and the pudendal nerve block.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Caudal Block | Injectable 1 ml/kg of 0.25% ropivacaine with 1mcg/kg dexmedetomidine into caudal spinal space. First attempt will be landmark-guided into the caudal spine region. Subsequent attempt(s) may be done using ultrasound. |
| PROCEDURE | Ultrasound-guided Pudendal Block | Injection of 0.5 ml/kg per side of injectable 0.2-0.3% ropivacaine with 0.5 mcg/kg dexmetomedine. Ultrasound-guided injection into each pudendal nerve region through skin of buttocks. |
| DRUG | Injectable 1 ml/kg of 0.25% ropivacaine with 1mcg/kg dexmedetomidine | Injectable 1 ml/kg of 0.25% ropivacaine with 1mcg/kg dexmedetomidine into caudal spinal space. First attempt will be landmark-guided into the caudal spine region. Subsequent attempt(s) may be done using ultrasound. |
| DRUG | Injection of 0.5 ml/kg per side of injectable 0.2-0.3% ropivacaine with 0.5 mcg/kg dexmetomedine. | Injection of 0.5 ml/kg per side of injectable 0.2-0.3% ropivacaine with 0.5 mcg/kg dexmetomedine. Ultrasound-guided injection into each pudendal nerve region through skin of buttocks. |
Timeline
- Start date
- 2023-03-06
- Primary completion
- 2025-02-01
- Completion
- 2025-05-01
- First posted
- 2023-02-01
- Last updated
- 2024-07-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05708989. Inclusion in this directory is not an endorsement.